Ivan Morgunov presents the scientific rationale for combining AAV9-Follistatin gene therapy with VEGF plasmid gene therapy to support complementary aspects of muscle health: muscle growth and vascular support. He will share Unlimited Bio’s preclinical data and initial clinical data collected to date